Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
A Study of LY2801653 in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel
- Status
- COMPLETED
- Phase
- N/A
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
- Status
- TERMINATED
- Phase
- PHASE2
High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of GSK1120212 Plus Gemcitabine vs Placebo Plus Gemcitabine in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Metformin Combined With Chemotherapy for Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision
- Status
- TERMINATED
- Phase
- PHASE2